Humans serve as both host and reservoir for Mycobacterium tuberculosis, making tuberculosis a theoretically eradicable disease. How M. tuberculosis alternates between host-imposed quiescence and sporadic bouts of replication to complete its life cycle, however, remains unknown. Here, we identify a metabolic adaptation that is triggered upon entry into hypoxia-induced quiescence but facilitates subsequent cell cycle re-entry. Catabolic remodelling of the cell surface trehalose mycolates of M. tuberculosis specifically generates metabolic intermediates reserved for re-initiation of peptidoglycan biosynthesis. These adaptations reveal a metabolic network with the regulatory capacity to mount an anticipatory response.
Humans serve as both host and reservoir for Mycobacterium tuberculosis, making tuberculosis a theoretically eradicable disease. How M. tuberculosis alternates between host-imposed quiescence and sporadic bouts of replication to complete its life cycle, however, remains unknown. Here, we identify a metabolic adaptation that is triggered upon entry into hypoxia-induced quiescence but facilitates subsequent cell cycle re-entry. Catabolic remodelling of the cell surface trehalose mycolates of M. tuberculosis specifically generates metabolic intermediates reserved for re-initiation of peptidoglycan biosynthesis. These adaptations reveal a metabolic network with the regulatory capacity to mount an anticipatory response.
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), kills more humans than any other bacterium, yet humans remain its only major natural reservoir. Replication of the bacillus is slowed or arrested in most hosts, but resumes in some only decades later, with a host response that is frequently fatal yet linked to the generation of infectious aerosols that enable completion of its life cycle 1 . Such delayed replication has allowed infected hosts to have offspring before transmitting the infection 2 . M. tuberculosis has thus come to depend on the regulation of cell cycle exit and re-entry as a critical mediator of pathogenicity and survival as a species.
Hypoxia is a physiological feature common to many of the intraand extracellular niches of M. tuberculosis in humans and experimentally infected animals 3 . In vitro, hypoxia arrests M. tuberculosis's replication and renders phenotypic tolerance to nearly all clinically used TB drugs [3] [4] [5] . However, M. tuberculosis also re-encounters atmospheric oxygen when inflammatory host tissue damage has become extensive enough to erode into the airways, facilitating re-entry into the cell cycle 1 . Hypoxia and atmospheric oxygen have thus co-evolved as highly correlated but temporally sequential features of the physiology of M. tuberculosis.
Studies of M. tuberculosis's response to hypoxia have revealed a broad and diverse range of responses, most of which have been considered in the physiological context of situational adaptation [6] [7] [8] [9] [10] . Here, we report a functionally distinct set of metabolic adaptations that are triggered by, but facilitate survival through and recovery from, hypoxia. These adaptations thus reveal a predictive regulatory capability of M. tuberculosis's metabolic network in which the temporal relationship between hypoxia and re-aeration has been encoded into an anticipatory response that links entry into and exit from dormancy.
Using our previously described in vitro system 7 , we noted that exposure to hypoxia (1% O 2 , 5% CO 2 ) triggered discrete accumulations of intermediates in the early portion of glycolysis, the pentose phosphate pathway and aminosugar biosynthesis. These accumulations occurred with glucose or acetate as a carbon source and reversed with re-aeration ( Fig. 1 and Supplementary Fig. 1a,b) . These changes were further linked to reciprocal, hypoxia-dependent decreases in levels of the downstream glycolytic intermediate, phosphoenolpyruvate (PEP) and upstream disaccharide, trehalose, but not further upstream glycogen polysaccharide stores ( Supplementary  Fig. 2a,b ). These changes, albeit to varying degrees, were also durable to the experimental limit of this system (4 days) without a measurable loss of viability and dissociated from tricarboxylic acid (TCA) cycle activity, as tested by the inclusion of nitrate, a physiological alternative terminal electron acceptor capable of supporting near aerobic levels of TCA cycle activity in hypoxic environments ( Supplementary Fig. 2c,d) 7 .
Upon transferring M. tuberculosis from unlabelled to uniformly 13 C-labelled ([U-13 C]) glucose or acetate at the time of exposure to hypoxia, we noted that these metabolite accumulations predominantly and unexpectedly occurred within the unlabelled fraction of each pool ( Fig. 1 and Supplementary Fig. 1a,b ), suggesting catabolism of a pre-existing metabolic store. Trehalose is a highly abundant, non-reducing disaccharide of glucose that can serve as both carbohydrate store and bioprotectant 11 . In M. tuberculosis, trehalose is also a core component of mycolyl glycolipids. Trehalose monomycolate (TMM) and di-mycolate (TDM), widely known as cord factor, form the outer lipid barrier of M. tuberculosis's cell envelope and serve as potent triggers of host inflammation 12 . We therefore hypothesized that the foregoing metabolic accumulations arose from hypoxia-induced catabolism of M. tuberculosis's cell surface trehalose mycolates. Consistent with a recent lipidomic study 13 , we observed a rapid and extreme depletion of M. tuberculosis's TMMs and TDMs during hypoxia, while levels of sulfolipids and the plasma membrane phospholipid-phosphatidylethanolamine-were unchanged ( Fig. 2a and Supplementary Fig. 3 ). Moreover, we observed linked changes in intra-, but not extra-, cellular levels of unlabelled trehalose (which decreased) and free mycolates (which increased), consistent with the release, re-uptake and catabolism of mycolyl glycolipid-derived trehalose ( Fig. 2a,b ).
TDM is a ligand of the Mincle receptor of macrophages and a potent inducer of the pro-inflammatory cytokines interleukin-12 (IL-12) and tumour-necrosis factor (TNF) 12 . We hypothesized that the hypoxia-induced decreases in TDM and TMM levels might be accompanied by changes in levels of M. tuberculosis-elicited IL-12p40 and TNF secretion. Incubation of mouse bone-marrowderived macrophages with equivalent numbers of paraformaldehyde-fixed M. tuberculosis cells revealed that hypoxia reversibly halved M. tuberculosis's ability to induce both cytokines ( Fig. 2c ), suggesting a potential functional link between M. tuberculosis's metabolism and immunoreactivity during exit from and re-entry into the cell cycle.
To gain further insight into the dynamics of this cell envelope remodelling, we incubated M. tuberculosis in [U-13 C] glucose for 2 days to enable labelling of glycolipids and then transferred to unlabelled glucose for 18 h to 'wash out' 13 C label from the glycolytic and pentose phosphate pathway intermediates but maintain 13 C-enriched pools of labelled trehalose ( Supplementary Fig. 4a ). We then subjected M. tuberculosis to hypoxia in the presence of unlabelled acetate as the carbon source. As shown in Supplementary  Fig. 4b ,c, we observed the same hypoxia-induced changes in trehalose and hexose phosphate pools but now in the 13 C-labelled fraction of each pool, indicating their origin in pre-existing depots of trehalose mycolates and free trehalose, respectively.
M. tuberculosis encodes three annotated enzymatic pathways capable of metabolizing trehalose: OtsA-OtsB, TreS and Rv2402 ( Supplementary Fig. 5a ) 11 . Biochemical and genetic studies indicate that the OtsA-OtsB pathway functions primarily in the biosynthetic direction 14 , while an Rv2402 deletion mutant exhibited no defect in trehalose utilization ( Supplementary Fig. 5b ). In contrast, both biochemical and genetic studies indicate that TreS is a catalytically competent trehalose synthase capable of reversibly interconverting maltose and trehalose, enabling conversion of trehalose to glucose in vivo 14, 15 . We therefore generated a treS-deletion strain of M. tuberculosis (ΔtreS) and genetically complemented counterpart to test the role and essentiality of treS in the foregoing response ( Supplementary Fig. 5c ). As expected, ΔtreS M. tuberculosis exhibited a selective growth defect in media containing trehalose, but not glucose, as the sole exogenous carbon source ( Supplementary Fig. 5d ).
Metabolic profiling studies showed that ΔtreS M. tuberculosis failed to exhibit the same metabolite accumulations observed in wild-type M. tuberculosis and treS complemented strain at early time points after exposure to hypoxia ( Fig. 3 ). ΔtreS M. tuberculosis was also unable to adapt to, or recover from, incubation at 1% O 2 ( Supplementary Fig. 5d ). We could similarly reproduce these effects using a validated chemical inhibitor of TreS, validamycin A ( Supplementary Fig. 6a -c) 14 . Thus, while wild-type M. tuberculosis exhibited a modest, hypoxia-induced repression of treS transcription in response to hypoxia ( Supplementary Fig. 6d ), these data identify a functionally essential, though not exclusive, role for TreS.
The foregoing results indicate that hypoxia triggers a catabolic remodelling of M. tuberculosis's immunostimulatory cell envelope, part of which is shunted into a stable accumulation of pentose phosphate pathway intermediates. The pentose phosphate pathway furnishes reducing equivalents for reductive biosynthesis and anti-oxidant defence and precursors for nucleotide and 13 C labelling achieved following transfer to [U-13 C] acetate-containing m7H10 medium under the condition indicated. All values are the average of three biological replicates (n = 3) ± s.e.m. and representative of two independent experiments. DHAP, dihydroxyacetone phosphate; GADP, glyceraldehyde phosphate; GlcNAc-P, N-acetyl glucosamine phosphate; hexose-P, glucose-6-phosphate and its isomers; pentose-P, ribose-5-phosphate and its isomers; PEP, phosphoenolpyruvate; sedoheptulose-P, sedoheptulose-7-phosphate and its isomers.
aromatic amino-acid synthesis 16 . Metabolomic profiling, however, revealed marked and specific accumulations of pentose phosphates and sedoheptulose phosphates in the absence of significant (greater than twofold) changes in NADP(H) levels or ratios, or aromatic amino acids ( Supplementary Fig. 7 ), and a metabolically unrelated accumulation of N-acetylglucosamine phosphate ( Fig. 1 and Supplementary Fig. 1a,b) . These changes suggested a potential role for pentose phosphate pathway intermediates in de novo peptidoglycan biosynthesis. To investigate this possibility, we tracked the fate of these accumulated unlabelled intermediates during re-entry into the cell cycle by transferring M. tuberculosis into 13 C-labelled media upon re-aeration. As expected, the majority of monitored metabolites exhibited time-dependent increases in 13 C labelling 7 . However, there were specific increases in total levels of PEP, uridine diphosphate (UDP)-N-acetylglucosamine and UDP-N-acetylglucosamine enoylpyruvate 30 min after re-aeration that were primarily mediated by increases in their unlabelled pools, which derive, in part, from the previously accumulated pool of N-acetylglucosamine phosphate ( Fig. 4 ). PEP is a thermodynamically trapped enol that furnishes the carboxyvinyl moiety bridging the glycan and peptide portions of mature peptidoglycan. UDP-N-acetylglucosamine enoylpyruvate is the first committed intermediate in peptidoglycan biosynthesis and arises from the enol ether transferase, MurA 17, 18 . These results thus link the hypoxia-induced catabolism of M. tuberculosis's trehalose mycolates to a metabolic program that poises M. tuberculosis to re-initiate peptidoglycan biosynthesis upon re-aeration.
Based on these findings, we tested the functional role of this response during recovery from hypoxia. To do so, we compared the susceptibilities of aerobic, hypoxic and re-aerated M. tuberculosis to a discrete (24 h) exposure of ampicillin, a covalently reactive inhibitor and functional probe of peptidoglycan biosynthesis. As expected, hypoxic M. tuberculosis exhibited a phenotypic tolerance to ampicillin and streptomycin compared to aerobic counterparts (as reported by time to outgrowth following treatment and subculture into fresh antibiotic-free medium). Re-aerated M. tuberculosis, in contrast, exhibited a return to near aerobic levels of susceptibility to ampicillin, but not streptomycin, during the first 24 h of re-aeration ( Supplementary Fig. 8a,b ). These results thus link the observed biochemical response to an early, specific and essential role for de novo peptidoglycan biosynthesis during recovery from hypoxia.
Growing evidence indicates that genetic regulatory systems have evolved the capacity to encode anticipatory responses to conserved spatiotemporal features of the environment that can prepare organisms for a given condition in advance of its arrival [19] [20] [21] . The capacity of non-genetic molecular networks to encode similar anticipatory responses has not been described. Our studies now expand this regulatory capability to include a metabolic network.
Metabolic enzymes catalyse biochemical reactions that typically occur on the order of seconds to minutes, but serve physiological activities that operate across a far broader range of timescales. Metabolic enzymes are a well-documented determinant of M. tuberculosis's pathogenicity 22 . However, the specific roles they play remain incompletely described. Ascribed roles have chiefly consisted of reactive situational responses. Yet, survival of M. tuberculosis ultimately depends on its ability to re-enter and complete the cell cycle following prolonged, and often unpredictable, periods of host-induced quiescence, posing a distinct regulatory challenge. Traditional stimulus-specific responses help meet the challenge of unpredictability, in part, through probabilistic, bet-hedging mechanisms 19 . In contrast, our studies identify a deterministically encoded mechanism in which the temporal relationship between hypoxia and environmental oxygen in M. tuberculosis's life cycle has been encoded into an anticipatory metabolic response, where hypoxia serves as a cue for the subsequent arrival of oxygen.
Peptidoglycan is an essential component of the cell wall required for both structural integrity and growth of virtually all bacteria, including M. tuberculosis. De novo synthesis of peptidoglycan begins with the condensation of two thermodynamically activated substrates, PEP and UDP-N-acetylglucosamine, by MurA, the first committed enzyme of the pathway. However, hypoxic M. tuberculosis maintains adenosine triphosphate (ATP) at levels approximately five times lower than those of replicating counterparts 7, 23 . The hypoxiainduced shunting of catabolized trehalose mycolates into activated pentose phosphate intermediates may thus help M. tuberculosis overcome a key thermodynamic barrier to cell cycle re-entry and completion of its life cycle, consistent with recently emerging reports of additional O 2 -sensitive mechanisms of MurA regulation 8, 24 .
The mechanisms used to accumulate, store and release trehalose mycolate-derived intermediates in M. tuberculosis remain to be determined. Existing evidence implicates the Antigen 85 complex, which generates trehalose as a by-product of the biosynthesis of the mycolic acid-based outer cell envelope; the LpqY-SugA-SugB-SugC ABC transporter, which catalyses the specific, retrograde transport of extracellular trehalose; the TreS-encoded trehalose synthase, described here; and glyceraldehyde-3-phosphate dehydrogenase, which was recently shown to regulate flux between upper and lower glycolysis via its universally conserved requirement for high P i (inorganic phosphate) concentrations 11, 25, 26 .
Mechanism notwithstanding, growing evidence indicates that the lesions in which M. tuberculosis resides within the lung are both diverse and dynamic 27 . The evolution of anticipatory responses may thus help M. tuberculosis bridge the challenge of navigating an often decades-long life cycle on an intermediary basis.
We previously reported that, unlike other bacteria, replicating M. tuberculosis operates its intermediary metabolism in a modular and compartmentalized manner by co-catabolizing different carbon sources to distinct metabolic fates 28 . Our discovery of metabolism of cell surface-derived trehalose to functionally compartmentalized pentose phosphate intermediates now expands this view to another pathway and M. tuberculosis in a hypoxic, non-replicating state. This work more broadly demonstrates a metabolically encoded regulatory capability that enables a critical transition point in a pathogen's life cycle. All values are the average of three biological replicates (n = 3) ± s.e.m. and representative of two independent experiments. DHAP, dihydroxyacetone phosphate; GADP, glyceraldehyde phosphate; GlcNAc-P, N-acetyl glucosamine phosphate; hexose-P, glucose-6-phosphate and its isomers; pentose-P, ribose-5-phosphate and its isomers; PEP, phosphoenolpyruvate; sedoheptulose-P, sedoheptulose-7-phosphate and its isomers.
Methods
M. tuberculosis filter culture and metabolite extraction. M. tuberculosis strains H 37 Rv, treS knockout (ΔtreS KO) and the complemented strain (ΔtreS::ptreS) were cultured in a biosafety level 3 facility at 37°C in Middlebrook 7H9 broth (m7H9) or on 7H10 agar (m7H10) (Difco) supplemented with 0.2% acetate (or 0.2% glucose in case of requirement), 0.04% Tyloxapol (broth only), 0.5 g l -1 BSA and 0.085% NaCl. M. tuberculosis-laden filters used for metabolic profiling were generated as previously described 7 and incubated at 37°C for 5 days to reach the mid-log phase of growth. M. tuberculosis-laden filters were then transferred onto chemically identical medium containing fresh 12 The residual protein content of metabolite extracts (BCA protein assay kit, Thermo Scientific) was determined to normalize the samples to cell biomass. Trehalase, amyloglucosidase and trehalose synthase-specific inhibitor (validamycin A) were purchased from Sigma-Aldrich. Validamycin A was used at either 5 or 10 mM concentration. Ampicillin and streptomycin were purchased from Sigma-Aldrich and used at 100 µg ml -1 (8× minimum inhibitory concentration (MIC)) and 1.5 µg ml -1 (2× MIC), respectively. All data obtained by metabolomics were averages of independent triplicates.
In vitro hypoxia model. In vitro hypoxia was achieved using a type A Bio-bag environmental chamber (Becton Dickinson), as specified by the manufacturer's instructions and validated by a resazurin indicator, which decolourized at oxygen concentrations of 1.0% or less. M. tuberculosis-laden filters were transferred to fresh chemically equivalent m7H10 immediately before insertion or after recovery from sealed hypoxic chambers. M. tuberculosis-laden filters recovered from hypoxic chambers were immediately plunged into the precooled quenching solution as described in ref. 7. This system gradually depletes oxygen and generates CO 2 via a palladium catalyst, achieving a final atmosphere of ∼1% O 2 (as reported by a resazurin-based indicator strip) and ∼5% CO 2 , levels similar to those encountered in the tuberculous lungs of infected animals, within 4 h. We previously showed that, in this system, M. tuberculosis neither underwent net replication nor death in response to incubation at 1% O 2 , and resumed growth upon re-aeration. We further showed that this system was associated with both the reversible biphasic induction of dosR, a previously validated transcriptional marker of hypoxia, and accompanying reductions of levels of ATP and nicotinamide adenine dinucleotide (NAD). matrix-associated ion suppression effects. The abundance of extracted metabolite ion intensities was extracted using Profinder 6.0 and Qualitative Analysis 6.0 (Agilent Technologies). The clustered heat map and hierarchical clustering trees were generated using Cluster 3.0 and Java TreeView 1.0.
LC-MS lipidomic analysis. Total lipid extraction was performed with minor modification as described previously 29 . Total lipids were extracted from the M. tuberculosis-laden filters that were used for metabolomics profiling. Three M. tuberculosis-laden filters were combined for each experimental condition to enable enough total lipid to be acquired to be detected by LC-MS. After collection, cells were washed twice in ice-cold PBS, transferred to a 50 ml amber glass bottle and contacted with 15 ml CHCl 3 /CH 3 OH (2:1, vol/vol) overnight to sterilize bacteria and extract total lipids simultaneously. After centrifugation, lipid extracts were decanted, and bacteria pellets were subjected to two additional extractions using CHCl 3 :CH 3 OH (1:1, vol/vol) and CHCl 3 :CH 3 OH (1:2, vol/vol) with pooling of all extracts and evaporation with N-EVAP (Organomation Associates) using the low boiling point mixture setting. Dried lipids were resuspended in a minimum volume of CHCl 3 :CH 3 OH (1:1, vol/vol) and dried under nitrogen in preweighed vials, then reweighed in triplicate on a microbalance (Mettler Toledo, XP205); values were reported when fully dried as shown by replicate measurements showing less than 1% variance. Using 2 mg of lipid extract, replicate measures showed a variance of 20 µg, providing mass errors below 1% for in vitro-derived samples. Extracts were then redissolved in CHCl 3 :CH 3 OH (1:1, vol/vol) at 1 mg ml -1 . LC-MS-grade solvents (Fisher) and clean borosilicate glassware (Fisher), amber vials (Supelco) and Teflon-lined caps (Fisher) were used.
Intrabacterial trehalose and glycogen assays. Intrabacterial trehalose and glycogen concentrations under varying metabolic states (replicating, non-replicating and reaeration) were measured by using Glucose (GO) Assay Kit (Sigma-Aldrich). The GO assay kit allows quantitative determination of glucose content present in bacterial extracted materials. Extracted glucose is oxidized to gluconic acid and hydrogen peroxide by glucose oxidase. Hydrogen peroxide then reacts with o-dianisidine in the presence of peroxidase to form a coloured product, reaction with sulfuric acid with which forms a more stable coloured product. The intensity of the coloured final product can be measureable at 540 nm which is proportional to the glucose amount extracted. Extractions of intrabacterial trehalose and glycogen were similarly performed as does for the extraction of M. tuberculosis metabolites. M. tuberculosisladen filters were incubated for 5 days on m7H10, transferred to fresh chemically identical m7H10 under either ambient, hypoxic or re-aerated after incubation under 24 h hypoxia and harvested the cytosolic materials by mechanical lysis with 0.1 mm Zirconia beads in a Precellys tissue homogenizer for 3 min (6,500 r.p.m.) twice under continuous cooling at or below 2°C. PBS was used for both washing twice and extracting cytosolic fraction. Extracted cytosolic fraction containing both trehalose and glycogen was used as a substrate for intermediate enzyme mixture containing either trehalase or amyloglucosidase to produce glucose, proportional to the amount of either trehalose or glycogen, respectively. Intrabacterial glucose produced was quantitated by using Glucose (GO) Assay kit. Known concentration of authentic trehalose or glycogen was used for generation of standard curves and a positive control. 13 C pulse chase labelling of cell envelope TMM. To selectively 13 C label M. tuberculosis trehalose mycolates, we applied the following experimental approach ( Supplementary Fig. 4a ). To fully 13 C label all intermediates in cells, we first incubated M. tuberculosis-laden filters on m7H10 containing [U-13 C] glucose for 2 days (all metabolites detected in our setting were greater than 99% 13 C labelled). We then transferred the M. tuberculosis-laden filters to fresh m7H10 containing unlabelled glucose for 18 h to replace 13 C labelled metabolites in the central carbon metabolism with unlabelled intermediates (around 67% trehalose and 9% hexose phosphate were remained as labelled with 13 C; reverse-washing step) ( Supplementary Fig. 4a lower panel) . Under these condition, we transferred M. tuberculosis-laden filters to fresh m7H10 containing either unlabelled or [U-13 C] acetate for up to 12 h of hypoxia and metabolites were sampled in a time dependent manner as described in previous section. The quantity and 13 C labelling pattern were analysed by LC-MS as previously described 7 .
Mutant strain generation. The rv0126 deficient knock-out mutant (ΔtreS) was generated in the M. tuberculosis H 37 Rv background as previously used. ΔtreS was constructed via a suicide plasmid approach ( Supplementary Fig. 5 ). Approximately 500 bp fragments corresponding to regions upstream (primer set; treS #1 and treS #2) and downstream (primer set; treS #3 and treS #4) of treS gene were amplified by PCR and cloned into a temperature-sensitive vector pDE43-XSTS to flank the hygromycin resistance cassette and generate pKO-XSTS-M. tuberculosis treS. H 37 Rv was first transformed with pKO-XSTS-M. tuberculosis treS and plated on m7H10 with hygromycin at the permissive temperature of 30°C. Transformants were then grown at 30°C to OD 580 = ∼1.0 and plated on m7H10 with hygromycin, 10% sucrose, 0.2% glycerol and 0.2% glucose at the restrictive temperature of 40°C. For complementation of ΔtreS, we generated pGMEK-phsp60-M. tuberculosis treS (primer set; Compl #1 and Compl #2), a vector that expresses treS under the control of the hsp60 promoter and wild type TreS are constitutively expressed episomally.
The rv2402 deficient knock-out mutant (Δrv2402) was generated similarly ( Supplementary Fig. 5b) . The treS or rv2402 deletion was confirmed by PCR amplification (primer set of pcr#1 and pcr#2) comparing with wild type H 37 Rv counterpart.
Primer sequences corresponding to Supplementary Fig. 5b ,c are as follows: Supplementary Fig. 5b : rv2402 #1: GGGGACAACTTTGTATAGAAAAGTTGACCAGGGTGATGCTCGTATGC; rv2402 #2: GGGGACTGCTTTTTTGTACAAACTTG GGCGAACTGGAC GATAGAGC; rv2402 #3: GGGGACAGCTTTCTTGTACAAAGTGG CACCTGGC ACTGATCAAC; rv2402 #4: GGGGACAACTTTGTATAATAAAGTTG CTGTTTGCCGTGTTCCTC; pcr #1: CAGCTCAATGGGTGAGAAG; pcr #2: TCC TCGGTGAAGGTGGATG; Supplementary Fig. 5c : treS #1: GGGGACAAC TTTGTATAGAAAAGTTGGGCCACAGGTGGTCA ACATC; treS #2: GGGGAC TGCTTTTTTGTACAAACTTGCTGCCTCGTTCATTGCTTCC; treS #3: GGGGACAGCTTTCTTGTACAA AGTGGACACGGGTTCTACTGGTTCC; treS #4: GGGGACAACTTTGTATAATAAAGTTGTCGATCGTTGGCGCGTA CTC; pcr #1: GACAGGTGGTCGGTATGAAC; pcr #2: CTGTTCGGCGTCACATACCC; Compl #1: GGGGACAA GTTTGTACAAAAAAGCAGGCTGATTCCTGGCGGC AAGTCTC; Compl #2: GGGGACCACTTTGTACAAG AAAGCTGGGTTC GTTGGCGGACGACATTG.
Antibiotic susceptibility of replicating and non-replicating M. tuberculosis. The relative sensitivity of aerobic, hypoxic and re-aerated M. tuberculosis to ampicillin (a covalent inhibitor of peptidoglycan biosynthesis) or streptomycin was determined by measuring the time to outgrowth in 96-well plates following a 24 h challenge with ampicillin at 8× MIC (100 µg ml -1 ) or streptomycin at 2× MIC (1.5 µg ml -1 ), after which bacteria were diluted 1:100 and monitored for growth by optical density. Experiments comprised biological triplicates and were repeated in at least two independent experiments.
Isotopologue analysis using isotope-labelled carbon sources. The extent of isotopic labelling for metabolites was determined by dividing the summed peak height ion intensities of all labelled isotopologue species by the ion intensity of both labelled and unlabelled species, expressed as a percentage. Label-specific ion counts were corrected for naturally occurring 13 C species (that is, [M+1] and [M+2]). The relative abundance of each isotopically labelled species was determined by dividing the peak height ion intensity of each isotopic form (corrected for naturally occurring 13 C species, as above) by the summed peak height ion intensity of all labelled species. Ion intensities were converted into molar abundances using standard curves generated by the addition of chemical standards and serial dilution of samples to establish the co-linearity of ion intensity and molar abundance 29 .
M. tuberculosis viability assay. M. tuberculosis viability was determined using liquid cultures manipulated under conditions experimentally identical to the filter-grown cultures used for metabolomics profiling, which we previously demonstrated to be microbiologically similar. Colony-forming units (c.f.u.) were determined by plating on m7H10 with supplements (0.2% glycerol, 0.2% glucose, 0.5 g l -1 BSA and 0.085% NaCl). All cell viability analyses were performed in triplicate in two independent experiments.
Macrophage cytokine enzyme-linked immunosorbent assays (ELISAs). Mouse bone-marrow-derived macrophages (BMMs) were collected from eight-to ten-week-old C57BL/6 mice and differentiated in cell culture as described in ref. 30 . A total of 2 × 10 5 macrophages per well in 24-well plates were exposed to single-cell suspensions of paraformaldehyde-fixed M. tuberculosis recovered from replicating, non-replicating (hypoxic) or re-aerated cultures taken from the early log phase of growth at a multiplicity of infection (MOI) of 3 and 5. Four hours following exposure, cells were washed twice with PBS to remove extracellular bacteria and replaced with fresh medium. Supernatants from M. tuberculosis-exposed macrophages were collected 24 h later, and cytokines IL-12 and TNF-α were measured by ELISA (R&D Systems). Supernatant from mock-treated macrophages was used as a control. Three independent experiments were performed for each infection condition. Bacterial input was determined by plating serial dilutions on m7H10 plates at 37°C and enumerating c.f.u.s after 2 weeks of incubation. We fixed M. tuberculosis under replicating, non-replicating and re-aerated states by treatment with 4% formaldehyde followed by washing with PBS twice before macrophage infection. Bacterial input was determined before fixing.
Measurement of trehalose secretion from M. tuberculosis culture. As previously described, the filter culture system used for metabolomics studies was modified by replacing the underlying m7H10 agar medium with a plastic inset containing chemically equivalent m7H9 liquid medium (without Tyloxapol) in direct contact with the underside of the M. tuberculosis-laden filter 7 . Growth on top this new device enabled timed start-stop measurements of trehalose secretion by sampling the cell-free liquid medium. A time-dependent trehalose secretion was sampled in the medium following exposure to and incubation under hypoxia and measured using LC-MS.
Measurement of intrabacterial NADPH/NADP ratios. M. tuberculosis-laden filters, as used for metabolomics profiling, were separately generated to measure intrabacterial NADPH and NADP content and their ratio. NADPH and NADP concentrations were measured using a FluroNADP/NADPH detection kit (Cell Technology). The metabolism of M. tuberculosis was rapidly quenched by plunging bacilli into the first solvent in the kit (cooled to <4°C).
Statistical analysis. Analyses were performed using the analysis of variance (ANOVA) test. A P value of less than 0.05 was considered statistically significant.
Data availability. The data that support the findings of this study are either available within this Letter and its supplementary information files or upon reasonable request to the corresponding author.
